“COVISHIELD” trade mark dispute: Cutis Biotech v. Serum Institute of India

Recently, a commercial court in Pune refused to pass an interim injunction order[1] to restrain the Serum Institute of India (SII) (defendant)[2] – the world’s largest vaccine manufacturer, from using the trade mark “COVISHIELD” for its vaccine for the coronavirus pandemic. Cutis Biotech[3] (plaintiff), a Nanded-based pharmaceutical and medicinal products company operating since 2010, had filed the suit in the civil court on 4-1-2021, seeking to restrain the SII from using the trade mark “COVISHIELD” or any other identical and/or similar name for its Covid-19 vaccine.

Read the full article HERE.

If you have any queries, please contact us.

Cookie Consent with Real Cookie Banner